Immix Biopharma prices 11,363,637 share offering at $11.00 raising $125 million gross
Immix Biopharma priced an underwritten offering of 11,363,637 common shares at $11.00 each, for gross proceeds of about $125 million before underwriting discounts and expenses. Closing is expected on or about Sept. 30, 2026.